|
Stories from the dialysis comunity across the globe.
|
|
CDC warns of carbenepam resistant Enterobacter (CRE superbug) |
|
|
|
Wired: Dr. Thomas Frieden, director of the US Centers for Disease Control and Prevention, said both Tuesday, during a press conference announcing new CDC statistics on the advance of the highly drug-resistant bacteria known as CRE. His language — plus the fact that he conducted the entire press conference himself, instead of just making a brief opening statement — seem to me a clear signal that the CDC is taking this resistance problem seriously, and hoping we do too.
|
|
|
High salt diet linked to activation of Th-17 helper cells and multiple sclerosis in mice. |
|
|
|
BBC: David Hafler, professor of immunobiology at Yale, told BBC news online: "In mouse models of MS, those fed high-salt diets had significantly worse disease. "We were all really quite surprised to see how changes in dietary salt could have such a profound effect."
|
|
Eulerian video magnification to monitor dialysis patients. |
|
|
|
NY Times: Ok, maybe not yet. But why not? :-) As a detector for IDH?
|
|
|
Fatal allergic reactions to Omontys (peginesatide) trigger recall. |
|
|
|
MedPage: All lots of the new anemia drug peginesatide (Omontys) have been recalled because of severe hypersensitivity reactions -- some fatal -- observed after the drug was approved last March. "No new or existing patients should receive Omontys," according to a statement from the two firms selling the drug, Affymax and Takeda. However, they stopped short of saying the product was being withdrawn from the market.
|
|
Hemodialysis abstracts from upcoming Annual Dialysis Conference in Seattle. |
|
|
|
HDI: Hemodialysis Abstracts from the 33rd Annual Dialysis Conference 24th Annual Symposium on Pediatric Dialysis Seattle, Washington, March 9-12, 2013
|
|
|
|
|
<< Start < Prev 441 442 443 444 445 446 447 448 449 450 Next > End >>
|
|
Page 445 of 4210 |